Clinical Trial Update: Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating interferon alfa with or without thalidomide for metastatic kidney cancer; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Thalidomide (thalidomide)

Snippet

Sponsor: Cancer Research UK | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN